Baptist Health is an important innovation collaborator for Philips in North America, and has been the first to install many advanced technologies from the company in the U.S., including the Azurion next generation image-guided therapy platform, MR Ingenia Ambition and IntelliSpace Portal image post-processing platform. The health system has also helped Philips deliver and clinically validate industry-firsts in 3D abdominal imaging.
Moreover, together, Baptist Health and Philips are advancing the application of data beyond traditional reporting and diagnostic utility, and toward predictive and prescriptive capabilities. Supported by the Baptist Health Center for Advanced Analytics (CAA), Philips will look to advance data-enabled objectives in the realms of predictive analytics, optimizing clinical, financial and operational processes, and making faster, data-driven decisions. These projects typify the innovation ambitions of Dr. Katzen and Mark E. Coticchia, the Baptist Health Corporate Vice President for Innovation, ensuring that doctors, patients and the local communities in Miami and South Florida continue to benefit from the most cutting-edge solutions available.
This collaboration will benefit from Philips’ technology footprint across hardware, software, service and solution innovation, and the breadth and depth of Baptist Health clinical expertise, its diverse patient population, and underlying data. The organizations will innovate together in cardiovascular disease management, oncology (notably in informatics and workflows), neurological disease, orthopedics and sports medicine, patient monitoring, and population health and wellness.
Both Baptist Health and Philips have a shared commitment to innovation and excellence, as well as putting the patient experience and outcomes front and center. Together, they look to improve patient care for the South Florida community, while building the future of healthcare innovation.